“…Given the continuous aging of the world population, the question to prevent the degradation of cognitive abilities linked to age, and, notably, of memory capacities, is of ever-increasing importance that requires constant therapeutic research. Several decades of preclinical investigations have shown that cognitive impairment associated with physiological or pathological aging is the result of functional deregulation in brain neural networks [ 66 , 67 , 68 ]. The NMDAR subtype of glutamate receptors is critical for the expression of functional plasticity at synapses such as long-term potentiation, which is viewed as the molecular basis of memory formation [ 62 , 69 , 70 , 71 , 72 ], and data have accumulated to show that the expression and/or activity of NMDARs are impacted by age [ 8 , 11 , 12 , 73 ].…”